Recent developments in floating drug delivery systems for gastric retention of drugs, an overview

Indian Drugs

Volumn 43, Issue 9, 2006, Pages 697-704

  Shirwaikar, A A ^a   Kumar, S M R ^a   Jacob, S ^a   Rashi, W ^a   Ravi, K ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Floating drug delivery systems; Gastric emptying time; Gastro intestinal tract; Oral controlled release

Indexed keywords

EID: 77953841344     PISSN: 0019462X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Kim H.K. and Brahma N. Singh. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J.Control. Release., 2000, 63, 235-259.
2. st edition; Vallabh Prakashan, Delhi, 2002, 156, 201, 196.
3. Kawashima Y., Niwa T., Takeuchi H. and Ito H. Preparation of multiple unit hollow microspheres with acrylic resin containing tranilast and their drug release characteristics (in vitro) and floating behaviour (in vivo). J.Control. Release., 1991, 16, 279-290.
4. Rouge N., Leroux J.C., Cole E.T., Doelker E. and Burt P. Prevention of the sticking tendency of floating mini tablets filled into hard gelatin capsules. Eur. J. Pharm. Biopharm., 1997, 43, 165-171.
5. Hilton A.K. and Deasy P.B. In vitro and in vitro evaluation of an oral sustained release dosage forms of amoxicillin trihydrate. Int. J. Pharm., 1992, 86, 79-80.
6. Desai S. and Bolton S. A floating controlled release drug delivery system, in vitro and in vivo evaluation. Pharm. Res., 1993, 10, 1321-1325.
7. Menon A., Ritschel W.A. and Sarkar A. Development and evaluation of a monolithic floating dosage form for furosemide. J. Pharm. Sci., 1994, 83, 239-245.
8. Kohri N., Naasari I. and Mitataki K. Improving the oral bioavailability of sulpiride by a gastric retained form in rabbits. J. Pharm. Pharmacol., 1995, 48, 371-374.
9. Arati A.D., Navnit H.S., Christopher T.R. and Waseem M. Development of a novel controlled release systems for gastric retention. Pharm. Res., 1997, 14, 809-812.
10. Iannuccelli V., Coppi G., Sansone R. and Ferolla G. Air compartment multiple unit system for prolonged gastric residence. Part-I. Formulation study. Int. J. Pharm., 1998, 174, 47-54.
11. Yang L., Eshragi J. and Fassihi R.J. A new intra gastric delivery system for the treatment of Helico bacter pylori associated gastric ulcers: In vitro evaluations. J. Control. Release., 1999, 57, 215-222. (Pubitemid 29073437)
12. Ushimaru K. and Nakamichi H.S. Pharmaceutical preparations and a method of manufacturing them US Patent., 4,702,918, 1987.
13. Fell J.T., Whitehead L. and Collet J.H. Amoxycillin release from a floating dosage form based on alginates. Int. J. Pharm., 2000, 210, 45-49.
14. Mitra S.B. Sustained release oral medicinal delivery device. US Patent., 4,451,260, 1984.
15. Thanoo B.C., Sunny M.C. and Jayakrihnan A. Oral sustained release drug delivery systems using polycarbonate microspheres capable of floating on gastric fluid. J. Pharm. Pharmacol., 1993, 45, 21-24.
16. Baumgartnar S., Julijana K., Franc C. and Zorco B. Optimization of floating matrix tablets and evaluation of their gastric residence time. Int. J. Pharm., 2000,195, 125-135.
17. Bulgarelli E., Forni F. and Bernabei M.T. Effect of matrix composition and process condition on casein -gelatin beads floating properties. Int. J. Pharm., 2000, 198, 157-165.
18. Nur A.O. and Zhang J.S. Captopril floating and/or bioadhesive tablets: design and release kinetics. Drug Develop. Ind. Pharm., 2000, 26, 965-969.
19. Naggar V.F., El-Kamel A.H., Sokar M.S. and Al Gamal S. S. Preparation and evaluation of ketoprofen floating oral delivery system. Int. J. Pharm., 2001, 220, 13-21.
20. Fassihi R. and Talukider R. Gastro retentive delivery system: Hollow beads. Drug Develop. Ind. Pharm., 2004, 30, 405-412.
21. Rubinstein A. and Friend D.R. Specific Delivery to gastrointestinal tract. In: Polymeric site specific pharmacotherapy. Wiley: Chichester; 1994: 282-283.
22. Hashim H. and Li Wan Po A. Improving the release characteristics of water- soluble drugs from hydrophilic sustained release matrices by in-situ gas generation. Int. J. Pharm., 1987, 35, 201-209.
23. Ingani H.M., Timmermans J. and Moes A. J. Conception and in vivo investigation of peroral sustained release floating dosage forms with enhanced gastrointestinal transit. Int. J. Pharm., 1987, 35,157-164.
24. Ichikawa M., Watnabe S. and Miyake Y.A new multiple unit oral floating dosage system I -Preparation and invitro evaluation of floating and sustained release characteristics. J. Pharm. Sci., 1991, 80, 1062-1066.
25. Inouye K., Machida Y., Sannan T. and Nagni T. Buoyant sustained release tablets based on chitosan. Drug. Des. Del., 1988, 2, 165-175.
26. Umezawa H., Pepstatin floating mini capsules. US Patent., 4,101,650, 1978.
27. Stockwell A.F., Davis S.S. and Walker S.E. Invitro evaluation of alginate gel systems as sustained release drug delivery systems. J. Control. Release., 1986, 3, 167-175.
28. Ichikawa M., Watanabe S. and Miyake Y. Granule remain in stomach. US patent., 4844905, 1989.
29. Atyabi F., Sharma H.L., Mohammed H.A. H. and Fell J. T. Controlled drug release from coating floating ion exchange resin beads. J. Control. Release., 1996, 42, 25-28.
30. Todd R. S. and Fryers G.R. Cholestyramine compositions and method for treating biliary gastritis. US Patent., 4,172,120, 1979.